Sign In
Buy ADRO
$14.60
+0 (+0%)
At Close: May 27, 2022
Bank of New York Mellon Corp Has $302,000 Stock Position in Aduro BioTech Inc (NASDAQ:ADRO)
09:18am, Friday, 01'st May 2020
Bank of New York Mellon Corp grew its stake in shares of Aduro BioTech Inc (NASDAQ:ADRO) by 13.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commiss
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04:34pm, Tuesday, 28'th Apr 2020
Aduro Biotech (ADRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The "Cancer Vaccines Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
Investors Who Bought Aduro BioTech (NASDAQ:ADRO) Shares Five Years Ago Are Now Down 93%
12:33pm, Sunday, 12'th Apr 2020
Aduro BioTech, Inc. (NASDAQ:ADRO) shareholders will doubtless be very grateful to see the share price up 146% in the...
Cancer Vaccines Market - Growth, Trends, and Forecast (2020 - 2025)
09:33pm, Thursday, 09'th Apr 2020
The global cancer vaccines market is expected to witness a CAGR of 16. Certain factors that are driving the market’s growth include the increasing number of cancer cases, rising investments and gov
Aduro Biotech (ADRO) Down 3.1% Since Last Earnings Report: Can It Rebound?
03:30pm, Wednesday, 08'th Apr 2020
Aduro Biotech (ADRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aduro BioTech (NASDAQ:ADRO) Shares Down 13.2%
11:08am, Wednesday, 08'th Apr 2020
Shares of Aduro BioTech Inc (NASDAQ:ADRO) fell 13.2% on Tuesday . The stock traded as low as $2.48 and last traded at $2.49, 515,986 shares traded hands during trading. A decline of 57% from the avera
Aduro Biotech (ADRO) Gains As Market Dips: What You Should Know
09:50pm, Friday, 03'rd Apr 2020
Aduro Biotech (ADRO) closed the most recent trading day at $2.54, moving +1.2% from the previous trading session.
The "Global Cancer Vaccines Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
Has Aduro Biotech (ADRO) Outpaced Other Medical Stocks This Year?
03:30pm, Wednesday, 01'st Apr 2020
Is (ADRO) Outperforming Other Medical Stocks This Year?
Is it finally time to add an in-law flat for adult kids or parents to return home?
06:36pm, Thursday, 26'th Mar 2020
A separate, self-contained unit can help someone self-quarantine during the coronavirus crisis.
PDL BioPharma (PDLI) Misses on Q4 Earnings, To Dissolve by Year-End
04:16pm, Thursday, 12'th Mar 2020
PDL BioPharma's (PDLI) earnings lag estimates in the fourth quarter. The company announces plan to complete liquidation by the end of 2020.
Fly Intel: Pre-market Movers MRO;HOME;DKS;TRIL;BCYC;DOMO;SFIX;ADRO;MTN
01:28pm, Tuesday, 10'th Mar 2020
Fly Intel: Pre-market Movers MRO HOME DKS TRIL BCYC DOMO SFIX ADRO MTN
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TRACON Pharmaceuticals (TCON), Aduro BioTech (ADRO) and
